Biocon Ltd. — Regulatory Filings 2020

Aug 20, 2020

==> picture [92 x 39] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423

CIN : L24234KA1978PLC003417

www.biocon.com

Date of submission: August 20, 2020

To The Secretary BSE Limited Department of Corporate Services Phiroze Jeejeebhoy Towers, Dalal Street,Mumbai – 400 001	To The Secretary National Stock Exchange of India Limited Corporate Communication Department Exchange Plaza, Bandra Kurla Complex Mumbai – 400 050
Scrip Code - 532523	Scrip Symbol- BIOCON

Dear Sir/Madam,

Sub: Meetings conducted with Institutional Investors/Research Analysts. Ref: Intimation under Regulation 30 (6) of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.

Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, we hereby inform you that the following meetings were conducted with Institutional Investor / Research Analysts:

Date	Name	Type of meeting	Location
August 19, 2020	Arohi Asset Management	Teleconferences - 1x1 & Group	Bangalore
	ArthequityAdvisors LLP
	Aurigin Capital
	Aviva Life Insurance
	Centrum PMS
	Chanakya Capital Services
	Consilium Investment Management
	Exide Life Insurance
	First State Investments
	Helios Capital
	LIC Mutual Fund
	Lloyd George Investments
	Malabar India
	Old Bridge Capital Management Pvt. Limited
	PerpetuityLLC
	Quantum Asset Management
	RWC Global EmergingMarkets
	SBI Pension Funds
	Siddhesh Capital Markets Services
	Tantallon Capital
	Tata AIA Life Insurance

We request you to kindly take above intimation on record.

Thanking You,

Yours faithfully,

For Biocon Limited

==> picture [78 x 30] intentionally omitted <==

==> picture [58 x 61] intentionally omitted <==

---

Mayank Verma Company Secretary and Compliance Officer